Covalis Capital’s Sotera Health SHC Stock Holding History

Covalis Capital’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-277,730	Closed	-$7.62M	–	94
2020 Q4	$7.62M	Buy	+277,730	New	+$7.46M	1.64%	13

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Covalis Capital's SHC Position: Q1 2021 in Review

Covalis Capital sold out of Sotera Health (SHC) in Q1 2021, closing a stake of 277,730 shares — an estimated $7.62M sold.

Covalis Capital first reported a position in SHC in Q4 2020 and held it in 1 quarter. The position peaked at $7.62M in Q4 2020. 132 funds tracked by Wall St. Rank hold SHC as of Q1 2021.

Covalis Capital reported no remaining Sotera Health position as of Q1 2021 after selling out during the quarter.
Covalis Capital sold 277,730 Sotera Health shares in Q1 2021, an estimated $7.62M.
Covalis Capital first reported a position in Sotera Health in Q4 2020 and held it in 1 quarter.
Covalis Capital's Sotera Health position peaked at $7.62M in Q4 2020.
132 funds tracked by Wall St. Rank held Sotera Health as of Q1 2021.

Based on Covalis Capital's 13F filing for Q1 2021, filed 17 May 2021.